HGF和TGF-β_1在原发性肝癌根治性切除术后复发转移的作用
The Role of HGF and TGF - pi in Recurrence and Metastasis of Primary Liver Cancer after Radical Resection
摘要
原发性肝癌是我国最常见的恶性肿瘤之一,外科切除是目前治疗的最重要手段,但术后高复发转移率是影响疗效进一步提高的关键障碍.在关于肝癌复发转移的研究中,原发性肝癌根治术后某些生长因子水平的变化是当前研究的新热点.
出处
《中国临床医学》
2004年第2期260-261,共2页
Chinese Journal of Clinical Medicine
参考文献17
-
1NaKanishi K,Fujimoto J,Ueki T,et al. Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3 - Kinase. Clin Exp Metastasis, 1999, 17:507-514.
-
2He J, Li Q, Zaide W, et al. Increased ievei of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis. In Vivo, 1999,13:177- 180.
-
3Kamiyama T, Une Y,Uchino J, et al. Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines. Int J Oncol, 1998,12: 655 -659.
-
4Junbo H,Li Q, Zaide W,et al. Increased level of serum HGF(HSF) in liver cancer is associated with tumor metastasis. In Vivo, 1999,13(2): 177-180.
-
5Michalopoulos GK, DeFrances MC. Liver regeneration. Science, 1997,276: 60-66.
-
6Hu RH,Lee PH,Yu SC,et al. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma. Hepatogastroenterology, 1999, 46:1842- 1847.
-
7Picardo A,Karpoff HM, Ng B, et al. Partial hepatectomy accelerates local tumor growth potential roles of local cytocike activation. Surgery, 1998, 124:57-64.
-
8Ito N,Kawata SS,Tamurs S,et al. Expression of transforming growth factor- beta1 mRNA in human hepatocellular carcinoma. Jpn J Carcer Res, 1990,80:1202- 1205.
-
9Yuen MF, Hughes RD, Heneghan MA, et al. Expression of Fas antigen (cd95) in peripheral blood lymphocytes and in liver - infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma. Cancer, 2001, 92: 2135~2141.
-
10Bedossa P,Terris B,Franco D, et al. Transforming growth factor -beta1 receptor in normal, cirrhotic and neoplastic human livers. Hepatology,1995, 21:760.
二级参考文献12
-
111,Kim KW,Bae SK,Lee OH,et al. Insulin-like growth factor Ⅱ induced by hypoxia maycontribute to angiogenesis of human hepatocellular Carcinoma. Cancer Res,1998,58(2):348~351.
-
212,El Assal ON,Yamanoi A,Soda Y,et al. Clinical significance of microvessel density andvascular endothelial growth factor expression in hepatocellular carcinoma and surroundingliver:possible involvement of vascular endothelial growth factor in the angiogenesis ofcirrhotic liver. Hepatlogy,1998,27(6):1554~1558.
(
-
31,Regimbeau JM,Olivier F,Bai YS,et al. Is surgery for largehepatocellular carcinoma Justified. J Hepatol,1999,31(2):1062~1068.
-
42,Neaud V,Faouzi S,Guirouilh J,et al. Human hepatic myofibroblasts increase invasivenessof hepatocellular carcinoma cells:eidence for a role of hepatocyte growth factor.Hepatology,1997,26(6):1458~1463.
-
53,Picardo A,Howard M,Karpoff,et al. Partial hepatectomy accelerates local tumorgrowth:potential roles of local cytokine activation. Surgery,1998,124(1):57~64.
-
64,Santoni RE,Jenson MR,Thorgeirsson SS,et al. Disruption of the pRb/E2F pathway andinhibition of apoptosis are major oncogenic events in liver constitutively expresing c-mycand transforming growth factor alpha. Cancer Res,1998,58(1):123~130.
-
75,Tsai JF,Jeng JE,Chuang LY,et al. Elevated urinary transforming growth facyor-beta 1 asa tumor marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.Cancer,1997,76(2):244~254.
-
86,Pardoux C,Paturel CA,Chehimi J,et al. Functional interaction between TGF-β and IL-12in human primary allogeneic cytoxicity and proliferative response. JImmunol,1997,158(1):136~143.
-
97,Gressner AM,Lahme B,Mannherz HG,et al. TGF-beta-mediated hepatocellular apoptosis byrat and human hepatoma cells and primary rat hepatocytes. J Hepatol,1997,26(5):1079~1083.
-
108,Choi KS,Lim IK,Brady JN,et al. ICE-like protease(caspase)is involved in transforminggrowth factor beta l-mediated apoptosis in FaO rat hepatoma cell line.Hepatology,1998,27(2):415~422.
共引文献38
-
1刘超,王捷,熊茂明,李俊.TGF-β_1与大鼠肝移植免疫耐受的关系[J].岭南现代临床外科,2001,1(1):25-26.
-
2张新民,唐蜜.Smad_4mRNA、TGF-β_1在大肠癌中的表达与侵袭、转移的关系[J].医学临床研究,2004,21(6):620-621.
-
3孙航,余慧峰,吴传新,管小琴,刘杞.肝再生增强因子在肝癌细胞中的表达及意义[J].中华肝脏病杂志,2005,13(3):205-208. 被引量:13
-
4吴福生,郑树森,吴灵娇,丁伟,马志敏,王照明,滕理送,赵文和.肝细胞生长因子及其受体c-met在肝细胞癌中的表达与预后价值[J].中华外科杂志,2006,44(9):603-608. 被引量:17
-
5陈永富,伍筱梅,商健彪,赖清.肝癌射频消融术后的血管改变与疗效及残癌监控[J].现代临床医学生物工程学杂志,2006,12(2):111-113. 被引量:1
-
6张彤,黄伯华.原发性肝癌术后复发再切除术式分析[J].苏州医学院学报,1998,18(6):618-618.
-
7吴海生,金志明,郑起.TGF-β1与原发性肝细胞癌关系的研究进展[J].国际外科学杂志,2010,37(5):339-342. 被引量:1
-
8金若敏,张晓晨,陈长勋,孙峥嵘,沈玉如,刘涤,胡之壁.黄芪毛状根药理作用的研究[J].中国中药杂志,1999,24(10):619-621. 被引量:31
-
9刘超,王捷,陈双,邓美海,区庆嘉.肝再生与肝癌复发关系的初步探讨[J].中华肝胆外科杂志,1999,5(6):388-390. 被引量:1
-
10刘超,陈双,区庆嘉.转化生长因子-β_1及其Ⅱ型受体在肝细胞癌中的基因表达[J].中华外科杂志,1999,37(12):740-742. 被引量:2
-
1陶晓明,张华,黄敏,李虎生,陆敏.非霍奇金淋巴瘤患者血清中血管内皮细胞生长因子水平的研究[J].中华内科杂志,2004,43(11):862-863.
-
2Miller M.A.,Sandler A.D.,王经纬.两例血管内皮瘤患者血浆中血管内皮细胞生长因子水平升高[J].世界核心医学期刊文摘(儿科学分册),2005,0(11):60-60.
-
3孙艳丽,王立波,杨光.晚期乳腺癌血管内皮细胞生长因子水平的研究[J].中国妇幼保健,2010,25(32):4695-4696. 被引量:1
-
4余莲,陈隆天.白血病患者血清肿瘤特异性生长因子水平及其与治疗效果的关系[J].临床血液学杂志,2003,16(1):32-33.
-
5李学亮,孙桂珍.骨髓增生异常综合征患者血清肿瘤特异性生长因子水平及其临床意义[J].白血病.淋巴瘤,2003,12(6):349-350.
-
6柳灵,陈涛,任峥嵘,陈代萍.消化道恶性肿瘤放射介入治疗前后肿瘤特异性生长因子水平观察[J].国际检验医学杂志,2016,37(5):692-693. 被引量:1
-
7王敬萍,李宝兰,刘涌,古淑香,韦攀健,马玙.血管内皮细胞生长因子水平对肺癌预后的影响[J].北京医学,2004,26(5):294-296. 被引量:1
-
8王敬萍,李宝兰,刘涌,古淑香,韦攀健,马玙.血管内皮细胞生长因子水平对肺癌预后的影响[J].结核病与胸部肿瘤,2005(2):98-100.
-
9柳兴其,陈检芳.肺癌患者治疗前后血清白细胞介素-6、肿瘤坏死因子和血管内皮生长因子水平及其临床意义[J].中国现代医学杂志,2006,16(18):2776-2778. 被引量:17
-
10程黎.肝癌患者血清中肿瘤特异性生长因子水平与临床病理特征及预后的关系[J].中国普外基础与临床杂志,2015,22(8):995-997. 被引量:3